02627.HK
Ab&B Bio Tech Co Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 29.32
−1.01%Margins
Gross margin
58.3%
EBITDA margin
-70.0%
EBIT margin
-88.2%
Net margin
-99.7%
FCF margin
-154.0%
-701.6%
Return on equity
-16.2%
Return on assets
-21.6%
Return on invested capital
0.16x
Asset turnover
-HKD 233.2M
Cash from operations
HKD 0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025